Purple toe syndrome

Rare cases of purple toe syndrome, warfarin-induced skin necrosis, and there are reports of calciphylaxis with warfarin therapy. Purple toe syndrome is a complication characterized by cholesterol microembolization that causes purple lesions to develop on the toes and sides of the feet. Purple toe syndrome usually develops 3 to 8 weeks after the

After our patient was started on phenindione therapy, he developed relapsing purple toe syndrome. Similarly to warfarin, phenindione is a vitamin K dependent anticoagulant and the reappearance of purple toes consistent with a diagnosis of cholesterol microembolization syndrome confirmed the diagnosis.

Purple toes syndrome is a complication of oral anticoagulation characterized by a dark, purplish or mottled color of the toes, usually occurring between 3 to 10

by BT Hyman 2024 Cited by 214Abstract. The purple toes syndrome is a rare complication of oral anticoagulant therapy. Four patients who presented with purple toes syndrome several weeks

Purple toes syndrome is a complication of oral anticoagulation characterized by a dark, purplish or mottled color of the toes, usually occurring between 3 to 10

The patient in this photo has a condition known as blue toe syndrome, Blue (or purple) toe syndrome. J Am Acad Dermatol. 2024; 60(1):1-20.

Purple Toe Syndrome Associated With Vitamin K Antagonist Therapy.

by L Marinchev 2024 Cited by 1The blue (or purple) toe syndrome describes the development of a blue or violaceous discoloration in one or more toes in the absence of

Purple Toes Syndrome Associated with Warfarin Therapy in a Patient with Antiphospholid Syndrome. [Pharmacotherapy 23(5): , 2024. © 2024 Pharmacotherapy